Big Move For Artiva Biotherapeutics, Inc.
Mon, Dec 15, 2025 at 07:41 PM
Artiva Biotherapeutics, Inc. (ARTV:NASDAQ) jumped higher at $6.3, representing a gain of 90.9%. On Mon, Dec 15, 2025, ARTV:NASDAQ touched a New 2-Week High of $6.3. From Tue, Dec 02, 2025, the stock recorded 66.67% Up Days and 60.00% Green Days
The stock spiked on Fri, Oct 17, 2025 at $7.36 with a volume of 100M+.
About Artiva Biotherapeutics, Inc. (ARTV:NASDAQ)
Artiva Biotherapeutics is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers.
Top 10 Gainers:
- Radiopharm Theranostics Limited (RADX:NASDAQ), 149.53%
- Artiva Biotherapeutics, Inc. (ARTV:NASDAQ), 90.91%
- NetClass Technology Inc (NTCL:NASDAQ), 39.71%
- 3 E Network Technology Group Limited (MASK:NASDAQ), 36.35%
- Quipt Home Medical Corp. (QIPT:NASDAQ), 34.1%
- Kaixin Holdings (KXIN:NASDAQ), 33.73%
- AlphaVest Acquisition Corp (ATMV:NASDAQ), 31.3%
- Climb Bio, Inc. (CLYM:NASDAQ), 27%
- Click Holdings Limited (CLIK:NASDAQ), 26.32%
- Fenbo Holdings Limited (FEBO:NASDAQ), 23.26%